TidalSense raised €16.6 million to accelerate commercialisation in the UK and support globalisation of its respiratory diagnostic technology.
- Amount
- $18.9M
- Stage
- Series B
- Announced
- 24 July 2026
- Lead
- Cross Border Impact Ventures
- Other investors
- Cross-Border Impact Ventures, BGF, Airstream Capital, Foresight Group
- Use of funds
- Accelerate commercialisation in the UK, Ireland and Europe, support US market entry, and develop tests for additional respiratory conditions.
- Total raised
- $40M to date
- Checked
- Amount and date checked against the press source